<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01189162</url>
  </required_header>
  <id_info>
    <org_study_id>31/09</org_study_id>
    <nct_id>NCT01189162</nct_id>
  </id_info>
  <brief_title>High Flow Nasal Cannula (HFNC) Versus Nasal Intermittent Mandatory Ventilation (NIMV)for Respiratory Distress Syndrome (RDS): a Randomized, Controlled, Prospective Study</brief_title>
  <official_title>High Flow Nasal Cannula Versus Nasal Intermittent Mandatory Ventilation for Respiratory Distress Syndrome: a Randomized, Controlled, Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bnai Zion Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bnai Zion Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that while the extremely low birthweight (ELBW) infants (&lt;1000
      g) may need NIMV for the treatment of RDS, larger infants or the smaller ones post extubation
      may enjoy the comfort benefits associated with HFNC while getting coparable respiratory
      support to NIMV.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2010</start_date>
  <completion_date type="Anticipated">July 2016</completion_date>
  <primary_completion_date type="Anticipated">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The percent of infants who will fail NRS and need endotracheal ventilation or will be switched to another mode of NRS.</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical features on both methods</measure>
    <time_frame>1 year</time_frame>
    <description>Blood pressure, heart rate, respiratory rate, pulse oximetry saturation, and respiratory status prior to mechanical ventilation if needed according to arterial blood gas (PaO2, PCO2, pH), and &quot;time to stop nasal support&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>% of infants with neonatal morbidities on both methods</measure>
    <time_frame>1 year</time_frame>
    <description>Incidence of intraventricular hemorrhage (IVH), duration of mechanical ventilation, incidence of BPD (oxygen at 36 weeks post conceptional age to keep saturation&gt;92%), time until full feeds, and length of stay.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>% of infants with possible side effects on both methods</measure>
    <time_frame>1 year</time_frame>
    <description>Nasal trauma due to NRS, rate of air leak (pneumothorax), gastrointestinal perforation, irritability and discomfort assessed by a validated score</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Respiratory Distress Syndrome</condition>
  <arm_group>
    <arm_group_label>NIMV- nasal respiratory support</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Infants with RDS will be treateg with nasal intermittent mandatory ventilation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HFNC- nasal respiratory support with HFNC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Infants with RDS will be treated with nasal respiratory support with high flow nasal canulla</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NIMV with SLE ventilator vs HFNC via Vapotherm</intervention_name>
    <description>Nasal respiratory support for RDS</description>
    <arm_group_label>NIMV- nasal respiratory support</arm_group_label>
    <arm_group_label>HFNC- nasal respiratory support with HFNC</arm_group_label>
    <other_name>NIMV with SLE ventilator vs. HFNC via Vapotherm</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Gestational age between 24 to 34 and 6/7 weeks assessed by the obstetrical team from
             dating of last menstural period or ultrasound and weight &gt;1000 g for the initial
             treatment of RDS or &lt;35 weeks post extubation or for apnea of prematurity

          2. Infants with RDS who will need NRS as initial therapy or after extubation and for
             apnea of prematurity, 3. written informed consent.

        Exclusion Criteria:

          1. Significant morbidity apart from RDS including: cardiac disease (not including patent
             ductus arteriosus [PDA]), congenital malformation, or if they had cardiovascular or
             respiratory instability because of sepsis, anemia or severe intraventricular
             hemorrhage (IVH),

          2. Parents refuse consent.

          3. Unavailability of suitable ventilator.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amir Kugelman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bnai Zion Medical Cente</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bnai Zion Medical Center, Neonatal department</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amir Kugelman, MD</last_name>
      <phone>972-4-8359559</phone>
    </contact>
    <investigator>
      <last_name>Amir Kugelman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Kugelman A, Feferkorn I, Riskin A, Chistyakov I, Kaufman B, Bader D. Nasal intermittent mandatory ventilation versus nasal continuous positive airway pressure for respiratory distress syndrome: a randomized, controlled, prospective study. J Pediatr. 2007 May;150(5):521-6, 526.e1.</citation>
    <PMID>17452229</PMID>
  </reference>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 23, 2010</study_first_submitted>
  <study_first_submitted_qc>August 25, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 26, 2010</study_first_posted>
  <last_update_submitted>August 11, 2015</last_update_submitted>
  <last_update_submitted_qc>August 11, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 13, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Primary treatment of RDS and treatment of RDS post extubation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

